January 26, 2007

New Citations

A. A comprehensive up to date review of the treatment of acute GVHD with emphasis on management of refractory cases with secondary therapy.
Annotated Bibliography VIII. section i. GVHD in BMT and PBSC Hematopoietic Cell Transplants, Citation #9

B. A consensus statement regarding the diagnostic criteria for stem cell transplant-associated microangiopathy.
Annotated Bibliography XIV. Section V. Adverse Events in Cord Blood Transplantation; Miscellaneous, Citation #4

C. Sickle Cell Disease- Clinical Data
An article on circumstances of death in adults which indicates that the mean (± SD) age at death was 36 ± 11 years in this series.

An analysis of hospitalization rates and costs of care indicating that costs of inpatient care in one state have increased by 31% above inflation from 1995 to 2003.
Annotated Bibliography XII. section 1A. Citation #5 & Citation #6

D. Outcome in patients with Wisdott-Aldrich syndrome.
Annotated Bibliography VII. Section ii. Cord Blood Transplantation in Children, Congenital Disorders, Citation #4

E. Differentiation of cord blood-derived multilineage progenitor cells into respiratory epithelial cells.
Annotated Bibliography XVI. Stem Cell Plasticity and Regenerative Medicine Citation #11

F. Donor cell leukemia in patients transplanted with cord blood stem cells.
Annotated Bibliography XIV. Adverse Events in Cord Blood Transplantation, section iv. Citation #1

G. A conditioning regimen that has been used successfully in children with advanced hematologic malignancies.
Annotated Bibliography VII. Section i. Cord Blood Transplantation in Children, Malignant Disorders, Citation #5

H. Data on unrestricted somatic stem cells (USSCs) and mesenchymal cells from human cord blood.
Annotated Bibliography XIX. Section ii. Miscellaneous Topics: Mesenchymal Stem Cells Citation C & Citation D